ASCO Data Position Contenders In Battle Of The SERDs
Wave Of Oral SERDs Approach Market
With at least two potential candidates being touted as potential best-in-class by their sponsors, the oral SERD market is shaping up to be highly competitive. Sanofi has taken an early lead in expanding the scope of its Phase III breast cancer program.
